Citation Impact
Citing Papers
Clinical Practice Guideline for Diagnostic Testing for Adult Obstructive Sleep Apnea: An American Academy of Sleep Medicine Clinical Practice Guideline
2017 Standout
Targeting the KEAP1-NRF2 System to Prevent Kidney Disease Progression
2017 Standout
Metabolic Syndrome: Treatment of Hypertensive Patients
2007
Triglyceride-rich lipoproteins inhibit cholesterol efflux to apolipoprotein (apo) A1 from human macrophage foam cells
2004
Multiple Biomarkers for the Prediction of First Major Cardiovascular Events and Death
2006 Standout
Effects of Flavonoids and other Polyphenols on Inflammation
2011 Standout
Prevalence of chronic kidney disease and decreased kidney function in the adult US population: Third national health and nutrition examination survey
2002 Standout
Cardio-Pulmonary-Renal Interactions
2015
COPD Guidelines: A Review of the 2018 GOLD Report
2018 Standout
Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure
2003 Standout
Fibrosis and Adipose Tissue Dysfunction
2013 Standout
The mechanisms of action of metformin
2017 Standout
Revisiting the evidence on health and health care disparities among the Roma: a systematic review 2003–2012
2013 Standout
2007 Guidelines for the Management of Arterial Hypertension
2007 Standout
Multi-Ethnic Study of Atherosclerosis: Objectives and Design
2002 Standout
Acute kidney injury
2019 Standout
The prevalence of calcified carotid artery atheromas on the panoramic radiographs of patients with type 2 diabetes mellitus
2000
“CEM” risk factors and severity of obstructive sleep apnoea in central European Roma and non-Roma patients referred for a diagnostic polysomnography
2010
Diabetes and Atherosclerosis
2002 Standout
Glycation impairs high-density lipoprotein function
2000
Clinician’s Guide to Cardiopulmonary Exercise Testing in Adults
2010 Standout
Obesity, obstructive sleep apnoea and metabolic syndrome
2011
Management of Chronic Kidney Disease Patients in the Intensive Care Unit: Mixing Acute and Chronic Illness
2017 Standout
Albuminuria and Risk of Cardiovascular Events, Death, and Heart Failure in Diabetic and Nondiabetic Individuals
2001 Standout
What We Talk About When We Talk About Fat
2014 Standout
Long-term effects of resveratrol supplementation on suppression of atherogenic lesion formation and cholesterol synthesis in apo E-deficient mice
2008
The pharmacogenetics of metformin
2017
Preventing Foot Ulcers in Patients With Diabetes
2005 Standout
Advanced glycation end-products: a review
2001 Standout
Dietary obesity-associated Hif1α activation in adipocytes restricts fatty acid oxidation and energy expenditure via suppression of the Sirt2-NAD+ system
2012
Cytochrome P450 enzymes in drug metabolism: Regulation of gene expression, enzyme activities, and impact of genetic variation
2013 Standout
Diabetic cardiomyopathy: Mechanisms and new treatment strategies targeting antioxidant signaling pathways
2014
Chronic Kidney Disease and the Risks of Death, Cardiovascular Events, and Hospitalization
2004 Standout
High-Density Lipoprotein Subfractions - What the Clinicians Need to Know
2013 Standout
Functionally Defective High-Density Lipoprotein: A New Therapeutic Target at the Crossroads of Dyslipidemia, Inflammation, and Atherosclerosis
2006 Standout
Peripheral vascular disease and Virchow's triad for thrombogenesis
2002
A cross-sectional study of the prevalence and associations of iron deficiency in a cohort of patients with chronic obstructive pulmonary disease
2015 StandoutNobel
2021 Guideline for the Prevention of Stroke in Patients With Stroke and Transient Ischemic Attack: A Guideline From the American Heart Association/American Stroke Association
2021 Standout
Kidney Disease as a Risk Factor for Development of Cardiovascular Disease
2003 Standout
Genome-Wide Association Study Identifies Two Novel Loci with Sex-Specific Effects for Type 2 Diabetes Mellitus and Glycemic Traits in a Korean Population
2014
Diabetic Nephropathy: Diagnosis, Prevention, and Treatment
2005 Standout
Validation of the Toronto Clinical Scoring System for Diabetic Polyneuropathy
2002
Diabetic Neuropathies
2005 Standout
The Prevalence of Metabolic Syndrome In Chronic Obstructive Pulmonary Disease: A Systematic Review
2016
Comprehensive Foot Examination and Risk Assessment
2008 Standout
Sex and Gender Differences in Risk, Pathophysiology and Complications of Type 2 Diabetes Mellitus
2016 Standout
Management of Hyperglycemia in Type 2 Diabetes, 2018. A Consensus Report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD)
2018 Standout
Diabetic Cardiomyopathy
2018 Standout
Adipocyte Pseudohypoxia Suppresses Lipolysis and Facilitates Benign Adipose Tissue Expansion
2014 StandoutNobel
Glycemic Control Is Related to the Morphological Severity of Diabetic Sensorimotor Polyneuropathy
2001
Pathophysiology of Type 2 Diabetes Mellitus
2020 Standout
Diabetic Neuropathies: Update on Definitions, Diagnostic Criteria, Estimation of Severity, and Treatments
2010 Standout
Endothelial Hypoxia-Inducible Factor-2α Is Required for the Maintenance of Airway Microvasculature
2019 StandoutNobel
Pharmacogenomics of Oral Antidiabetic Medications: Current Data and Pharmacoepigenomic Perspective
2011
The Metabolic Syndrome
2008 Standout
Diabetic Somatic Neuropathies
2004 Standout
Diabetic Neuropathy: A Position Statement by the American Diabetes Association
2016 Standout
Impairment of Ventilatory Efficiency in Heart Failure
2000
Detection, Quantification, and Characterization of Potentially Atherogenic Triglyceride-Rich Remnant Lipoproteins
1999
Prognostic Significance of Serum Creatinine and Uric Acid in Older Chinese Patients With Isolated Systolic Hypertension
2001
Is There a Pathogenetic Role for Uric Acid in Hypertension and Cardiovascular and Renal Disease?
2003 Standout
Scutellarin Isolated from <i>Erigeron multiradiatus</i> Inhibits High Glucose-mediated Vascular Inflammation
2008
Simple Screening Tests for Peripheral Neuropathy in the Diabetes Clinic
2001
The Vascular Endothelium and Human Diseases
2013 Standout
Longitudinal Follow-up and Outcomes Among a Population With Chronic Kidney Disease in a Large Managed Care Organization
2004 Standout
Hypoxemia in patients with COPD: cause, effects, and disease progression
2011
Effects of Disturbed Flow on Vascular Endothelium: Pathophysiological Basis and Clinical Perspectives
2011 Standout
Works of Ivan Tkáč being referenced
Important contribution of lipoprotein particle number to plasma triglyceride concentration in type 2 diabetes
1998
Increased Adipose Tissue Expression of Proinflammatory CD40, MKK4 and JNK in Patients with Very Severe Chronic Obstructive Pulmonary Disease
2010
Metabolic syndrome in relationship to type 2 diabetes and atherosclerosis
2005
Effect of sulphonylurea treatment on glycaemic control is related to TCF7L2 genotype in patients with type 2 diabetes
2010
Spirometric alterations in patients with reduced renal function.
1993
Glycemic Control Is Related to the Electrophysiologic Severity of Diabetic Peripheral Sensorimotor Polyneuropathy
1998
[Neuroendocrine changes in chronic heart failure].
1993
Metabolic Phenotype and Adipose Tissue Inflammation in Patients with Chronic Obstructive Pulmonary Disease
2010
Serum Creatinine Level is an Independent Risk Factor for the Angiographic Severity of Internal Carotid Artery Stenosis in Subjects Who Have Previously Had Transient Ischaemic Attacks
1998
Pharmacogenomic association between a variant in SLC47A1 gene and therapeutic response to metformin in type 2 diabetes
2012
Combined Analysis of Three Large Interventional Trials With Gliptins Indicates Increased Incidence of Acute Pancreatitis in Patients With Type 2 Diabetes
2016
Fibrinogen and Albuminuria are Related to the Presence and Severity of Peripheral Arterial Disease in Women with Type 2 Diabetes Mellitus
1997
Cardiovascular risk and insulin resistance in patients with obstructive sleep apnea.
2008
Carotid intima-media thickness in relation to macrovascular disease in patients with type 2 diabetes mellitus.
2000
The Severity of Coronary Atherosclerosis in Type 2 Diabetes Mellitus Is Related to the Number of Circulating Triglyceride-Rich Lipoprotein Particles
1997
Cardiovascular risk factors as predictors of mortality in type II diabetic patients.
1999